管理严重的双管大动脉狭窄症,大动脉缩和左心室功能受损
Oscar A Perez Orpinel1, Félix Damas de Los Santos2, Jessy Steve Masso-Bueso1
1Interventional Cardiology Department, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.
JACC. Case reports
|September 19, 2025
概括
在一位老年患者中,一种罕见的严重双大动脉狭窄和缩的罕见病例,通过逐步的穿皮疗法成功治疗. 这一策略改善了心脏功能,并减少了通过导管的大动脉置换的手术风险.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 结构性心脏病 结构性心脏病
背景情况:
- 双主动脉和主动脉的缩往往同时存在.
- 在老年人中诊断这些疾病并不常见.
- 这种病例在八十多岁的病人身上提出了独特的诊断和治疗挑战.
研究的目的:
- 描述一个成功的皮肤管理策略,对于一个复杂的严重双主动脉狭窄症和老年患者的缩病例.
- 突出一步一步的方法在高风险的患者联合结构性心脏缺陷的好处.
主要方法:
- 一名78岁的男性患有高血压,出现呼吸障碍.
- 诊断检查显示严重的双主动脉狭窄,主动脉缩,严重损害左心室缩功能 (排泄分数12%).
- 采用了一种逐步的皮肤穿刺方法,首先是对胸腔进行支架,然后是通过透导管更换大动脉.
主要成果:
- 凝心管支架将左心室喷射分数从12%提高到32%.
- 这一改进有助于成功地通过导管更换大动脉门.
- 这种逐步的方法减少了在手术期间需要心室支的需要.
结论:
- 一个循序渐进的穿皮策略,在主动脉置换之前解决缩,在管理具有复杂结构性心脏病的高风险老年患者中是有效的.
- 优先考虑缩治疗可以减少后负荷,改善缩功能,并简化随后的门干预.
- 在这些具有挑战性的案件中,精心的程序前规划对于成功的结果至关重要.
相关概念视频
Aortic Regurgitation III: Medical Management
399
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
399
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Cardiomyopathy V: Interprofessional Care
339
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
339
Mitral Stenosis IV: Nursing Management
247
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
247
Cardiomyopathy III: Hypertrophic Cardiomyopathy
414
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
414
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284


